Using MDMA as a PTSD Treatment

The world of treatments for post-traumatic stress disorder (PTSD) seemingly grows larger every day. The more time spent researching PTSD, the more varied the treatments seem to become. A new study has produced results suggesting MDMA, or Ecstacy, a “club drug,” can aid veterans undergoing psychotherapy to treat their PTSD. Apparently the MDMA allows the subjects to lower their fear of revisiting their trauma, a necessary step in treating PTSD, without inhibiting their emotional state which helps them fully engage in their own therapy.

The study’s focus was on those veterans who have suffered from PTSD for an average 19 years and who have failed to respond to the traditional treatments of psychotherapy and medication. The study consisted of 2 8-hour experimental psychotherapy sessions a month apart where 12 patients were given MDMA and 8 patients were given a placebo. Subjects also underwent psychotherapy sessions weekly before and after each experimental session. Independent psychologists appraised the subjects before and after the sessions.

The results of the study were more than impressive. Not only did 25% of the placebo group no longer meet the criteria to be diagnosed with PTSD, but over 80% of the group given MDMA no longer met the criteria. Prior to the study, 3 subjects were unable to work because of the debilitating nature of their PTSD symptoms. These 3 subjects were given MDMA during the study and following the study all 3 were able to return to work. Not one subject reported any drug-related side effects or neurocognitive problems.

While the results from this study are impressive, this was a very small and limited trial. There are still many safety issues with using MDMA that must be addressed before further trials can be undertaken.

If you are a disabled veteran who has been denied disability compensation or have not yet applied for benefits from the VA, contact Veterans Help Group. You may be entitled to certain programs and benefits so contact our veterans disability rights firm today.